BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23344827)

  • 1. Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality.
    Peña C; Gómez-Zorrilla S; Oriol I; Tubau F; Dominguez MA; Pujol M; Ariza J
    Eur J Clin Microbiol Infect Dis; 2013 Mar; 32(3):413-20. PubMed ID: 23344827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant Pseudomonas aeruginosa and mortality in mechanically ventilated ICU patients.
    Denis JB; Lehingue S; Pauly V; Cassir N; Gainnier M; Léone M; Daviet F; Coiffard B; Baron S; Guervilly C; Forel JM; Roch A; Papazian L
    Am J Infect Control; 2019 Sep; 47(9):1059-1064. PubMed ID: 30962023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinventing the wheel: Impact of prolonged antibiotic exposure on multidrug-resistant ventilator-associated pneumonia in trauma patients.
    Lewis RH; Sharpe JP; Swanson JM; Fabian TC; Croce MA; Magnotti LJ
    J Trauma Acute Care Surg; 2018 Aug; 85(2):256-262. PubMed ID: 29664891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs.
    Borgatta B; Gattarello S; Mazo CA; Imbiscuso AT; Larrosa MN; Lujàn M; Rello J
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2155-2163. PubMed ID: 28624864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiological survey of the quinolone- and carbapenem-resistant genotype and its association with the type III secretion system in Pseudomonas aeruginosa.
    Ferreira ML; Dantas RC; Faria ALS; Gonçalves IR; Silveira de Brito C; Queiroz LL; Gontijo-Filho PP; Ribas RM
    J Med Microbiol; 2015 Mar; 64(Pt 3):262-271. PubMed ID: 25596115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
    Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F
    Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa.
    Kaminski C; Timsit JF; Dubois Y; Zahar JR; Garrouste-Orgeas M; Vesin A; Azoulay E; Feger C; Dumenil AS; Adrie C; Cohen Y; Allaouchiche B;
    Crit Care; 2011; 15(2):R112. PubMed ID: 21481266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia.
    Hamet M; Pavon A; Dalle F; Pechinot A; Prin S; Quenot JP; Charles PE
    Intensive Care Med; 2012 Aug; 38(8):1272-9. PubMed ID: 22699790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
    Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
    J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.
    Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
    Intensive Care Med; 2006 Dec; 32(12):1970-8. PubMed ID: 16957901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of combination therapy and early de-escalation on outcome of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
    Deconinck L; Meybeck A; Patoz P; Van Grunderbeeck N; Boussekey N; Chiche A; Delannoy PY; Georges H; Leroy O
    Infect Dis (Lond); 2017 May; 49(5):396-404. PubMed ID: 28092204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.
    Parker CM; Kutsogiannis J; Muscedere J; Cook D; Dodek P; Day AG; Heyland DK;
    J Crit Care; 2008 Mar; 23(1):18-26. PubMed ID: 18359417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.
    Chung DR; Song JH; Kim SH; Thamlikitkul V; Huang SG; Wang H; So TM; Yasin RM; Hsueh PR; Carlos CC; Hsu LY; Buntaran L; Lalitha MK; Kim MJ; Choi JY; Kim SI; Ko KS; Kang CI; Peck KR;
    Am J Respir Crit Care Med; 2011 Dec; 184(12):1409-17. PubMed ID: 21920919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia.
    Depuydt PO; Vandijck DM; Bekaert MA; Decruyenaere JM; Blot SI; Vogelaers DP; Benoit DD
    Crit Care; 2008; 12(6):R142. PubMed ID: 19014695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classification.
    Micek ST; Kollef MH; Torres A; Chen C; Rello J; Chastre J; Antonelli M; Welte T; Clair B; Ostermann H; Calbo E; Wunderink R; Menichetti F; Schramm G; Menon V
    Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1190-7. PubMed ID: 26190444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
    Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
    Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures.
    Yang K; Zhuo H; Guglielmo BJ; Wiener-Kronish J
    Ann Pharmacother; 2009 Jan; 43(1):28-35. PubMed ID: 19033484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.